Heidelberg Pharma has made significant progress in the clinical development of HDP-101 in China. ...

Ascenion is offering another workshop in its Life Science Digital Hub, funded by GO-Bio initial:  ...

Ascenion's portfolio company Allogenetics has closed a significant pre-Series A financing round. The ...

The US Food and Drug Administration (FDA) has granted orphan drug designation to HepaRegeniX’s ...

The former x-cardiac GmbH has broadened its business focus and is now operating as Ascléa GmbH. At ...